206 related articles for article (PubMed ID: 24492474)
1. Inhibition of NOX/VPO1 pathway and inflammatory reaction by trimethoxystilbene in prevention of cardiovascular remodeling in hypoxia-induced pulmonary hypertensive rats.
Liu B; Luo XJ; Yang ZB; Zhang JJ; Li TB; Zhang XJ; Ma QL; Zhang GG; Hu CP; Peng J
J Cardiovasc Pharmacol; 2014 Jun; 63(6):567-76. PubMed ID: 24492474
[TBL] [Abstract][Full Text] [Related]
2. Magnesium Lithospermate B Derived from Salvia miltiorrhiza Ameliorates Right Ventricle Remodeling in Pulmonary Hypertensive Rats via Inhibition of NOX/VPO1 Pathway.
Li T; Peng JJ; Wang EL; Li NS; Song FL; Yang JF; Luo XJ; Liu B; Peng J
Planta Med; 2019 Jul; 85(9-10):708-718. PubMed ID: 30822814
[TBL] [Abstract][Full Text] [Related]
3. A novel pathway of NADPH oxidase/vascular peroxidase 1 in mediating oxidative injury following ischemia-reperfusion.
Zhang YS; He L; Liu B; Li NS; Luo XJ; Hu CP; Ma QL; Zhang GG; Li YJ; Peng J
Basic Res Cardiol; 2012 May; 107(3):266. PubMed ID: 22476986
[TBL] [Abstract][Full Text] [Related]
4. Coordination between NADPH oxidase and vascular peroxidase 1 promotes dysfunctions of endothelial progenitor cells in hypoxia-induced pulmonary hypertensive rats.
Wang EL; Jia MM; Luo FM; Li T; Peng JJ; Luo XJ; Song FL; Yang JF; Peng J; Liu B
Eur J Pharmacol; 2019 Aug; 857():172459. PubMed ID: 31216444
[TBL] [Abstract][Full Text] [Related]
5. Vascular peroxidase 1 mediates hypoxia-induced pulmonary artery smooth muscle cell proliferation, apoptosis resistance and migration.
You B; Liu Y; Chen J; Huang X; Peng H; Liu Z; Tang Y; Zhang K; Xu Q; Li X; Cheng G; Shi R; Zhang G
Cardiovasc Res; 2018 Jan; 114(1):188-199. PubMed ID: 29186367
[TBL] [Abstract][Full Text] [Related]
6. The role of NADPH oxidase in chronic intermittent hypoxia-induced pulmonary hypertension in mice.
Nisbet RE; Graves AS; Kleinhenz DJ; Rupnow HL; Reed AL; Fan TH; Mitchell PO; Sutliff RL; Hart CM
Am J Respir Cell Mol Biol; 2009 May; 40(5):601-9. PubMed ID: 18952568
[TBL] [Abstract][Full Text] [Related]
7. Magnesium lithospermate B prevents phenotypic transformation of pulmonary arteries in rats with hypoxic pulmonary hypertension through suppression of NADPH oxidase.
Li T; Luo XJ; Wang EL; Li NS; Zhang XJ; Song FL; Yang JF; Liu B; Peng J
Eur J Pharmacol; 2019 Mar; 847():32-41. PubMed ID: 30659826
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature.
Mittal M; Roth M; König P; Hofmann S; Dony E; Goyal P; Selbitz AC; Schermuly RT; Ghofrani HA; Kwapiszewska G; Kummer W; Klepetko W; Hoda MA; Fink L; Hänze J; Seeger W; Grimminger F; Schmidt HH; Weissmann N
Circ Res; 2007 Aug; 101(3):258-67. PubMed ID: 17585072
[TBL] [Abstract][Full Text] [Related]
9. Involvement of vascular peroxidase 1 in angiotensin II-induced hypertrophy of H9c2 cells.
Yang W; Liu Z; Xu Q; Peng H; Chen L; Huang X; Yang T; Yu Z; Cheng G; Zhang G; Shi R
J Am Soc Hypertens; 2017 Aug; 11(8):519-529.e1. PubMed ID: 27651140
[TBL] [Abstract][Full Text] [Related]
10. Vascular peroxidase 1 promotes phenotypic transformation of pulmonary artery smooth muscle cells via ERK pathway in hypoxia-induced pulmonary hypertensive rats.
Li T; Liu B; Li NS; Luo XJ; Peng JW; Peng J
Life Sci; 2022 Oct; 307():120910. PubMed ID: 36029851
[TBL] [Abstract][Full Text] [Related]
11. VPO1/HOCl/ERK pathway mediates the right ventricular remodeling in rats with hypoxic pulmonary hypertension.
Li T; Liu B; Luo XJ; Peng J
Arch Biochem Biophys; 2022 Jul; 723():109267. PubMed ID: 35483433
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol alleviate hypoxic pulmonary hypertension via anti-inflammation and anti-oxidant pathways in rats.
Xu D; Li Y; Zhang B; Wang Y; Liu Y; Luo Y; Niu W; Dong M; Liu M; Dong H; Zhao P; Li Z
Int J Med Sci; 2016; 13(12):942-954. PubMed ID: 27994500
[TBL] [Abstract][Full Text] [Related]
13. Effect of Tongxinluo on pulmonary hypertension and pulmonary vascular remodeling in rats exposed to a low pressure hypoxic environment.
Wang Y; Ma TT; Gao NN; Zhou XL; Jiang H; Guo R; Jia LN; Chang H; Gao Y; Gao ZM; Pan L
J Ethnopharmacol; 2016 Dec; 194():668-673. PubMed ID: 27737815
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation.
Shi W; Zhai C; Feng W; Wang J; Zhu Y; Li S; Wang Q; Zhang Q; Yan X; Chai L; Liu P; Chen Y; Li M
Life Sci; 2018 Oct; 210():140-149. PubMed ID: 30179628
[TBL] [Abstract][Full Text] [Related]
15. NADPH oxidase: its potential role in promotion of pulmonary arterial hypertension.
Peng JJ; Liu B; Xu JY; Peng J; Luo XJ
Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):331-338. PubMed ID: 28190244
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
[TBL] [Abstract][Full Text] [Related]
17. Salubrinal attenuates right ventricular hypertrophy and dysfunction in hypoxic pulmonary hypertension of rats.
He YY; Liu CL; Li X; Li RJ; Wang LL; He KL
Vascul Pharmacol; 2016 Dec; 87():190-198. PubMed ID: 27678416
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between expression of endothelial nitric oxide synthase and NADPH oxidase in lungs of mice exposed to chronic hypoxia].
Wu XL; DU LZ; Xu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Sep; 17(9):1001-6. PubMed ID: 26412187
[TBL] [Abstract][Full Text] [Related]
19. NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling.
Barman SA; Chen F; Su Y; Dimitropoulou C; Wang Y; Catravas JD; Han W; Orfi L; Szantai-Kis C; Keri G; Szabadkai I; Barabutis N; Rafikova O; Rafikov R; Black SM; Jonigk D; Giannis A; Asmis R; Stepp DW; Ramesh G; Fulton DJ
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1704-15. PubMed ID: 24947524
[TBL] [Abstract][Full Text] [Related]
20. Cystamine Treatment Fails to Prevent the Development of Pulmonary Hypertension in Chronic Hypoxic Rats.
Markvardsen LK; Sønderskov LD; Wandall-Frostholm C; Pinilla E; Prat-Duran J; Aalling M; Mogensen S; Andersen CU; Simonsen U
J Vasc Res; 2021; 58(4):237-251. PubMed ID: 33910208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
